EPISODE · Mar 7, 2022 · 20 MIN
Rethinking Your Market Access Strategy with Dinesh Kabaleeswaran, Sr. Dir. of Insights and Advisory at MMIT
from From Lab to Launch by Qualio · host Qualio & Dinesh Kabaleeswaran, Sr. Dir. of Insights and Advisory at MMIT
Today's episode we explore the ins and outs of market access strategy with Dinesh Kabaleeswaran, Sr. Dir. of Insights and Advisory at MMIT. Learn more about how to improve market access strategy with better data, payer and buyer insights, and what the medical device side of life sciences can learn from pharma's approach and speed to market access. About Dinesh:Dinesh Kabaleeswaran leads MMIT's Advisory & Insights teams, which provide market access context and a market research narrative for MMIT's data and technology products. Dinesh has more than seven years of managed care experience, advising large biopharmaceutical clients on pre- and post-launch strategies across oncology, non-oncology and immunology therapeutic areas. Dinesh holds a master’s in bioengineering from the University of Pennsylvania.Twitter: https://twitter.com/DineshKannanKa2LinkedIn: https://www.linkedin.com/in/dineshkannan/Recent articles by Dinesh: The Power of Partnerships: Why Pharma Needs to Redefine its Role With IDNs (Drug Channels) Market Access Speed Is the Next Critical Differentiator for Pharma Manufacturers (PharmExec) About MMITMMIT is regarded as a trusted go-to-market partner that identifies barriers to patient access and helps coordinate major stakeholders to move therapies from pipeline to prescription—answering the “what” of how payers cover therapies and the “why” behind those decisions. MMIT’s product portfolio has been built by listening to our clients, and with expert teams of pharmacists, clinicians, data specialists and market researchers who provide foresight, clarity and confidence. This is the hallmark of who we are and who we will always be.MMIT website: Mmitnetwork.com MMIT on LinkedIn: https://www.linkedin.com/company/mmit-managed-markets-insight-&-technology-/Show notesQualioPress Release: MMIT Announces Game-Changing Solution for Life Sciences CompaniesMMIT's Reality Check seriesPrevious episodes: https://www.qualio.com/from-lab-to-launch-podcastApply to be on the show: https://forms.gle/uUH2YtCFxJHrVGeL8Music by keldezQualio website:https://www.qualio.com/Previous episodes:https://www.qualio.com/from-lab-to-launch-podcastApply to be on the show:https://forms.gle/uUH2YtCFxJHrVGeL8Music by keldez
Embed this episode
What this episode covers
Today's episode we explore the ins and outs of market access strategy with Dinesh Kabaleeswaran, Sr. Dir. of Insights and Advisory at MMIT. Learn more about how to improve market access strategy with better data, payer and buyer insights, and what the medical device side of life sciences can learn from pharma's approach and speed to market access. About Dinesh: Dinesh Kabaleeswaran leads MMIT's Advisory & Insights teams, which provide market access context and a market researc...
NOW PLAYING
Rethinking Your Market Access Strategy with Dinesh Kabaleeswaran, Sr. Dir. of Insights and Advisory at MMIT
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.